Logo image of CDM1.DE

COEUR MINING INC (CDM1.DE) Stock Fundamental Analysis

FRA:CDM1 - Deutsche Boerse Ag - US1921085049 - Common Stock - Currency: EUR

7.868  -0.1 (-1.21%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to CDM1. CDM1 was compared to 39 industry peers in the Metals & Mining industry. CDM1 has only an average score on both its financial health and profitability. CDM1 is growing strongly while it is still valued neutral. This is a good combination!


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year CDM1 was profitable.
CDM1 had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CDM1 reported negative net income in multiple years.
CDM1 had a positive operating cash flow in each of the past 5 years.
CDM1.DE Yearly Net Income VS EBIT VS OCF VS FCFCDM1.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M -300M

1.2 Ratios

CDM1's Return On Assets of 2.98% is in line compared to the rest of the industry. CDM1 outperforms 53.85% of its industry peers.
The Return On Equity of CDM1 (4.42%) is comparable to the rest of the industry.
CDM1 has a Return On Invested Capital (3.15%) which is in line with its industry peers.
Industry RankSector Rank
ROA 2.98%
ROE 4.42%
ROIC 3.15%
ROA(3y)-2.22%
ROA(5y)-1.33%
ROE(3y)-4.55%
ROE(5y)-2.78%
ROIC(3y)N/A
ROIC(5y)N/A
CDM1.DE Yearly ROA, ROE, ROICCDM1.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

Looking at the Profit Margin, with a value of 10.11%, CDM1 is in the better half of the industry, outperforming 76.92% of the companies in the same industry.
Looking at the Operating Margin, with a value of 21.38%, CDM1 is in the better half of the industry, outperforming 74.36% of the companies in the same industry.
CDM1's Operating Margin has improved in the last couple of years.
With a decent Gross Margin value of 44.65%, CDM1 is doing good in the industry, outperforming 71.79% of the companies in the same industry.
CDM1's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 21.38%
PM (TTM) 10.11%
GM 44.65%
OM growth 3Y30%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.95%
GM growth 5Y13.16%
CDM1.DE Yearly Profit, Operating, Gross MarginsCDM1.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CDM1 is destroying value.
Compared to 1 year ago, CDM1 has more shares outstanding
CDM1 has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CDM1 has been reduced compared to a year ago.
CDM1.DE Yearly Shares OutstandingCDM1.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
CDM1.DE Yearly Total Debt VS Total AssetsCDM1.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

An Altman-Z score of 2.26 indicates that CDM1 is not a great score, but indicates only limited risk for bankruptcy at the moment.
CDM1 has a Altman-Z score (2.26) which is in line with its industry peers.
CDM1 has a debt to FCF ratio of 7.48. This is a slightly negative value and a sign of low solvency as CDM1 would need 7.48 years to pay back of all of its debts.
With a Debt to FCF ratio value of 7.48, CDM1 perfoms like the industry average, outperforming 51.28% of the companies in the same industry.
CDM1 has a Debt/Equity ratio of 0.17. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.17, CDM1 is doing good in the industry, outperforming 61.54% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 7.48
Altman-Z 2.26
ROIC/WACC0.33
WACC9.62%
CDM1.DE Yearly LT Debt VS Equity VS FCFCDM1.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

A Current Ratio of 1.93 indicates that CDM1 should not have too much problems paying its short term obligations.
CDM1 has a Current ratio of 1.93. This is in the better half of the industry: CDM1 outperforms 64.10% of its industry peers.
CDM1 has a Quick Ratio of 1.09. This is a normal value and indicates that CDM1 is financially healthy and should not expect problems in meeting its short term obligations.
CDM1 has a Quick ratio of 1.09. This is comparable to the rest of the industry: CDM1 outperforms 53.85% of its industry peers.
Industry RankSector Rank
Current Ratio 1.93
Quick Ratio 1.09
CDM1.DE Yearly Current Assets VS Current LiabilitesCDM1.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 283.33% over the past year.
Looking at the last year, CDM1 shows a very strong growth in Revenue. The Revenue has grown by 41.80%.
Measured over the past years, CDM1 shows a quite strong growth in Revenue. The Revenue has been growing by 8.18% on average per year.
EPS 1Y (TTM)283.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%320%
Revenue 1Y (TTM)41.8%
Revenue growth 3Y8.17%
Revenue growth 5Y8.18%
Sales Q2Q%69%

3.2 Future

The Earnings Per Share is expected to grow by 34.10% on average over the next years. This is a very strong growth
Based on estimates for the next years, CDM1 will show a quite strong growth in Revenue. The Revenue will grow by 13.56% on average per year.
EPS Next Y270.58%
EPS Next 2Y104.84%
EPS Next 3Y77.67%
EPS Next 5Y34.1%
Revenue Next Year65.05%
Revenue Next 2Y30.88%
Revenue Next 3Y22.51%
Revenue Next 5Y13.56%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CDM1.DE Yearly Revenue VS EstimatesCDM1.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B
CDM1.DE Yearly EPS VS EstimatesCDM1.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.5 -0.5 -1

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 28.10, the valuation of CDM1 can be described as expensive.
CDM1's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 28.04. CDM1 is around the same levels.
A Price/Forward Earnings ratio of 12.97 indicates a correct valuation of CDM1.
CDM1's Price/Forward Earnings ratio is in line with the industry average.
When comparing the Price/Forward Earnings ratio of CDM1 to the average of the S&P500 Index (37.64), we can say CDM1 is valued rather cheaply.
Industry RankSector Rank
PE 28.1
Fwd PE 12.97
CDM1.DE Price Earnings VS Forward Price EarningsCDM1.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CDM1 indicates a slightly more expensive valuation: CDM1 is more expensive than 69.23% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, CDM1 is valued a bit more expensive than 66.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF 88.8
EV/EBITDA 16.12
CDM1.DE Per share dataCDM1.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

CDM1's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CDM1's earnings are expected to grow with 77.67% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.1
PEG (5Y)N/A
EPS Next 2Y104.84%
EPS Next 3Y77.67%

0

5. Dividend

5.1 Amount

No dividends for CDM1!.
Industry RankSector Rank
Dividend Yield N/A

COEUR MINING INC

FRA:CDM1 (7/25/2025, 7:00:00 PM)

7.868

-0.1 (-1.21%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-06 2025-08-06/amc
Inst Owners76.39%
Inst Owner ChangeN/A
Ins Owners1.07%
Ins Owner ChangeN/A
Market Cap5.03B
Analysts80
Price Target9.7 (23.28%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1208.25%
Min EPS beat(2)-22.21%
Max EPS beat(2)2438.72%
EPS beat(4)3
Avg EPS beat(4)632.66%
Min EPS beat(4)-22.21%
Max EPS beat(4)2438.72%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)2.87%
Min Revenue beat(2)-6.45%
Max Revenue beat(2)12.19%
Revenue beat(4)2
Avg Revenue beat(4)0.95%
Min Revenue beat(4)-9.25%
Max Revenue beat(4)12.19%
Revenue beat(8)3
Avg Revenue beat(8)-5.57%
Revenue beat(12)5
Avg Revenue beat(12)-3.74%
Revenue beat(16)5
Avg Revenue beat(16)-3.92%
PT rev (1m)9.98%
PT rev (3m)21.61%
EPS NQ rev (1m)3.61%
EPS NQ rev (3m)81.05%
EPS NY rev (1m)1.42%
EPS NY rev (3m)24.33%
Revenue NQ rev (1m)2.17%
Revenue NQ rev (3m)11.89%
Revenue NY rev (1m)2.74%
Revenue NY rev (3m)14.51%
Valuation
Industry RankSector Rank
PE 28.1
Fwd PE 12.97
P/S 4.93
P/FCF 88.8
P/OCF 22.96
P/B 2.15
P/tB 2.71
EV/EBITDA 16.12
EPS(TTM)0.28
EY3.56%
EPS(NY)0.61
Fwd EY7.71%
FCF(TTM)0.09
FCFY1.13%
OCF(TTM)0.34
OCFY4.36%
SpS1.6
BVpS3.65
TBVpS2.9
PEG (NY)0.1
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.98%
ROE 4.42%
ROCE 6.75%
ROIC 3.15%
ROICexc 3.21%
ROICexgc 3.79%
OM 21.38%
PM (TTM) 10.11%
GM 44.65%
FCFM 5.55%
ROA(3y)-2.22%
ROA(5y)-1.33%
ROE(3y)-4.55%
ROE(5y)-2.78%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y27.91%
ROICexcg growth 5YN/A
ROICexc growth 3Y27.91%
ROICexc growth 5YN/A
OM growth 3Y30%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.95%
GM growth 5Y13.16%
F-Score7
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 7.48
Debt/EBITDA 1.17
Cap/Depr 135.76%
Cap/Sales 15.91%
Interest Coverage 250
Cash Conversion 64.83%
Profit Quality 54.9%
Current Ratio 1.93
Quick Ratio 1.09
Altman-Z 2.26
F-Score7
WACC9.62%
ROIC/WACC0.33
Cap/Depr(3y)275.87%
Cap/Depr(5y)228.93%
Cap/Sales(3y)35.55%
Cap/Sales(5y)31.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)283.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%320%
EPS Next Y270.58%
EPS Next 2Y104.84%
EPS Next 3Y77.67%
EPS Next 5Y34.1%
Revenue 1Y (TTM)41.8%
Revenue growth 3Y8.17%
Revenue growth 5Y8.18%
Sales Q2Q%69%
Revenue Next Year65.05%
Revenue Next 2Y30.88%
Revenue Next 3Y22.51%
Revenue Next 5Y13.56%
EBIT growth 1Y2523.57%
EBIT growth 3Y40.62%
EBIT growth 5YN/A
EBIT Next Year380.87%
EBIT Next 3Y86.89%
EBIT Next 5Y38.3%
FCF growth 1Y118.52%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y8807.43%
OCF growth 3Y16.39%
OCF growth 5Y13.65%